CLDN1 and breast carcinoma: The authors showed that the protein expressions of CLDN-1 were significantly higher in the basal-like subtype of breast cancers (ER-ve, Her-2-ve, EGFR+ve, CK5/6+ve, a subtype largely linked to poor outcome [40].